FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

PMA: P960013 · Supplement: S058 · Decision May 19, 2010
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
Trade Name
OPTISENSE 1999 LEAD
PMA Number
P960013
Supplement Number
S058
Device Class
FDA Class 3
Product Code
NVN
Generic Name
Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
May 19, 2010
Date Received
March 23, 2010
Supplement Type
Real-Time Process
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR NEW STYLETS TO BE INCLUDED IN THE OPTISENSE MODEL 1999 LEAD PACKAGE.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NVN Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes